clinical trial diversity

decentralized clinical trial hybrid clinical trial

COVID-19 and the Changing Landscape of Clinical Trials

 Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution. While the pandemic increased the industry’s acceptance of decentralized clinical trial protocols, moving to an entirely virtual model without in-person interaction is unrealistic. This sort of hybrid approach allows researchers …

COVID-19 and the Changing Landscape of Clinical Trials Read More »

Alzheimer's patient looking

Clinical Matters: Recruiting and Retaining Alzheimer’s Patients for Clinical Trials

With a greater understanding of the challenges facing patients, caregivers, and physicians, researchers can better structure Alzheimer’s disease studies to minimize barriers and improve participation. By providing direct support to participants from enrollment through the end of a clinical trial, logistics management companies establish and maintain a sense of trust between participants, caregivers, and site …

Clinical Matters: Recruiting and Retaining Alzheimer’s Patients for Clinical Trials Read More »

Patient Diversity in O&P trials

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients

Achieving Diversity in Orthotic and Prosthetic Clinical Trials Logistical and financial barriers have created significant barriers to clinical trial participation, resulting in historical under-representation of minority populations in clinical trials. As the industry seeks to counter past shortcomings, sponsors in the O&P space must utilize proactive strategies to recruit diverse populations to ensure appropriate diversity. …

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients Read More »

Clinical trial diversity

Achieving Clinical Trial Diversity Through Actionable Steps

The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and …

Achieving Clinical Trial Diversity Through Actionable Steps Read More »

Improving Patient Diversity, Access and Awareness in Rare Disease Clinical Trials

Members of ethnic communities around the globe suffer from rare diseases unique to their demographic group. Their genetic makeup makes them more susceptible to hereditary issues which affect generation after generation. Designing a trial and selecting participants with diverse backgrounds that proportionally represent each demographic group is one of the first steps a sponsor can …

Improving Patient Diversity, Access and Awareness in Rare Disease Clinical Trials Read More »

Diversity In Clinical Trials Image

Diversity in Clinical Trials: Going Beyond Why to How

Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective and sustainable solutions to create more diverse clinical trials. Our CEO, Scott Gray, joined Michael Causey, Editor-in-Chief, ACRP TV, to share his insight and practical methods for improving diversity in …

Diversity in Clinical Trials: Going Beyond Why to How Read More »